documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
29 rows where docket_id = "FDA-2003-N-0196" and posted_year = 2014 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2003-N-0196-0055 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Initial Determination and Feedback Letter from FDA/CDER to L'Oreal USA Products, Inc re Time and Extent Application (TEA) Drometrizole Trisiloxane for use in Over-the-Counter (OTC) Sunscreens | Other | Letter(s) | 2014-08-29T04:00:00Z | 2014 | 8 | 2014-08-29T04:00:00Z | 2014-08-29T21:20:12Z | 0 | 0 | 09000064818511a4 | ||
| FDA-2003-N-0196-0054 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Letter from FDA/CDER to BASF AG (Morgan, Lewis & Bockius LLP) | Other | Letter(s) | 2014-06-23T04:00:00Z | 2014 | 6 | 2014-06-23T04:00:00Z | 2014-06-23T18:14:09Z | 0 | 0 | 090000648175c494 | ||
| FDA-2003-N-0196-0053 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Supplement from BASF AG (Morgan Lewis & Bockius, LLP) | Other | Supplement (SUP) | 2014-06-11T04:00:00Z | 2014 | 6 | 2014-06-11T04:00:00Z | 2014-06-11T15:51:37Z | 0 | 0 | 090000648048b765 | ||
| FDA-2003-N-0196-0051 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Data and Information from BASF AG (Morgan Lewis & Bockius, LLP) | Other | Submission of Information | 2014-06-11T04:00:00Z | 2014 | 6 | 2014-06-11T04:00:00Z | 2014-06-11T15:48:23Z | 0 | 0 | 090000648173afac | ||
| FDA-2003-N-0196-0052 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Supplement from BASF AG (Morgan Lewis & Bockius, LLP) | Other | Supplement (SUP) | 2014-06-11T04:00:00Z | 2014 | 6 | 2014-06-11T04:00:00Z | 2014-06-11T15:49:59Z | 0 | 0 | 090000648048b660 | ||
| FDA-2003-N-0196-0048 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Letter from Symrise North America Cosmetic Division | Other | Letter(s) | 2014-06-09T04:00:00Z | 2014 | 6 | 2014-06-09T04:00:00Z | 2014-06-09T21:19:55Z | 0 | 0 | 090000648048b606 | ||
| FDA-2003-N-0196-0047 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Letter from Buchanan Ingersoll to the Division of Over-The-Counter Drug Products, July 25, 2003 | Other | Letter(s) | 2014-06-09T04:00:00Z | 2014 | 6 | 2014-06-09T04:00:00Z | 2014-06-09T21:12:37Z | 0 | 0 | 090000648048b600 | ||
| FDA-2003-N-0196-0049 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Letter from FDA/CDER to BASF AG (Morgan, Lewis & Bockius LLP) | Other | Letter(s) | 2014-06-09T04:00:00Z | 2014 | 6 | 2014-06-09T04:00:00Z | 2014-06-09T21:29:26Z | 0 | 0 | 090000648048b61b | ||
| FDA-2003-N-0196-0050 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Supplement from BASF AG (Morgan Lewis & Bockius, LLP) | Other | Supplement (SUP) | 2014-06-09T04:00:00Z | 2014 | 6 | 2014-06-09T04:00:00Z | 2014-06-09T22:01:14Z | 0 | 0 | 090000648048b622 | ||
| FDA-2003-N-0196-0039 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 8 Test Substance G 4375 Content in Rat Plasma re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:36:48Z | 0 | 0 | 090000648170431f | |||
| FDA-2003-N-0196-0044 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 12 Report re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:52:30Z | 0 | 0 | 090000648170445e | |||
| FDA-2003-N-0196-0040 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 7 Test Item G 4375 Content in Rat Plasma re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:37:09Z | 0 | 0 | 090000648170431e | |||
| FDA-2003-N-0196-0046 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 14 Clinical Evaluation of the Cutaneous Tolerance and Acceptance of a Cosmetic Product Applied Under Normal Conditions of Use in the Sun for Three Weeks by 30 Children re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-07-16T19:26:05Z | 0 | 0 | 0900006481704460 | |||
| FDA-2003-N-0196-0045 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 13 Pediatric Use Study Reports re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:57:41Z | 0 | 0 | 090000648170445f | |||
| FDA-2003-N-0196-0035 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 3 Admentment No. 1 to Final Report Dated 21 March 1996 re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:24:32Z | 0 | 0 | 090000648170431a | |||
| FDA-2003-N-0196-0037 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 5 Test to Evaluate PhotoAllergic in the Guinea Pig re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:30:13Z | 0 | 0 | 090000648170431c | |||
| FDA-2003-N-0196-0043 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 11 English Summary of the Report re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:48:46Z | 0 | 0 | 090000648170445d | |||
| FDA-2003-N-0196-0036 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 4 re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:29:41Z | 0 | 0 | 090000648170431b | |||
| FDA-2003-N-0196-0034 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 2 re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:24:53Z | 0 | 0 | 0900006481704319 | |||
| FDA-2003-N-0196-0042 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 10 Human Safety Study Reports re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:48:37Z | 0 | 0 | 090000648170445c | |||
| FDA-2003-N-0196-0038 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 6 Determination of G 4375 Content in Rat Plasma re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:30:31Z | 0 | 0 | 090000648170431d | |||
| FDA-2003-N-0196-0033 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 1 Time and Extension Application re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-07-16T19:23:25Z | 0 | 0 | 0900006481704318 | |||
| FDA-2003-N-0196-0041 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Volume 9 Test Report CCR Project 532003 re Data and Information from L'Oreal, USA Products, Inc. | Supporting & Related Material | Data | 2014-05-19T04:00:00Z | 2014 | 5 | 2014-05-19T22:44:43Z | 0 | 0 | 0900006481704320 | |||
| FDA-2003-N-0196-0031 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Response Letter from FDA CDER to Symrise, Inc., and Ego Pharmaceuticals Ltd re re Time and Extent Application TEA | Other | Letter(s) | 2014-02-28T05:00:00Z | 2014 | 2 | 2014-02-28T05:00:00Z | 2014-05-14T11:33:42Z | 0 | 0 | 09000064815e9304 | ||
| FDA-2003-N-0196-0030 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Request for Extension from BASF AG and BASF Corporation | Other | Request for Extension | 2014-02-14T05:00:00Z | 2014 | 2 | 2014-02-14T05:00:00Z | 2014-02-14T20:44:26Z | 0 | 0 | 090000648048b5fd | ||
| FDA-2003-N-0196-0025 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Amiloxate USP Neo Heliopan E1000 by Symrise Safety Data Book 2 | Other | References (internal) (REF) | 2014-01-07T05:00:00Z | 2014 | 1 | 2014-01-07T05:00:00Z | 2014-01-07T21:40:26Z | 0 | 0 | 09000064814f1dc2 | ||
| FDA-2003-N-0196-0027 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Amiloxate USP Neo Heliopan E1000 by Symrise Safety Data Book 4 | Other | References (internal) (REF) | 2014-01-07T05:00:00Z | 2014 | 1 | 2014-01-07T05:00:00Z | 2014-02-28T18:17:37Z | 0 | 0 | 09000064814f1dc4 | ||
| FDA-2003-N-0196-0024 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Amiloxate, USP - Neo Heliopan E1000 by Symrise Safety Data Book 1 (EU Commission Approval and Opinion of SCCNFP, Animal safety testing tabs 1-15) | Other | References (internal) (REF) | 2014-01-07T05:00:00Z | 2014 | 1 | 2014-01-07T05:00:00Z | 2014-01-07T21:40:20Z | 0 | 0 | 09000064814f1dc1 | ||
| FDA-2003-N-0196-0026 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 | Amiloxate USP Neo Heliopan E1000 by Symrise Safety Data Book 3 | Other | References (internal) (REF) | 2014-01-07T05:00:00Z | 2014 | 1 | 2014-01-07T05:00:00Z | 2014-01-07T21:40:32Z | 0 | 0 | 09000064814f1dc3 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);